1.Study on HPLC fingerprint characteristics of Selaginella plants.
Xiao-Lei FAN ; Ding-Rong WAN ; Cong-Jin YE ; Ke-Li CHEN
China Journal of Chinese Materia Medica 2007;32(20):2102-2106
OBJECTIVETo establish a method to analyze HPLC fingerprint characteristics of 10 plants from Selaginella.
METHODHPLC was applied for establishment of fingerprints, which were used to evaluate and distinguish the different species of Selaginella.
RESULTThe different species from Selaginella showed different HPLC fingerprint characteristic. The samples of the same species but collected in different period, different environment or different locations showed certain difference in fingerprints
CONCLUSION2 important mutual fingerprint peaks were found in the 10 plants of Selaginella species and 5 peaks can be used as "main fingerprint peaks". The dates of these peaks can used for assessment of phylogenetic relation among species and evaluation of quality.
Biflavonoids ; analysis ; China ; Chromatography, High Pressure Liquid ; methods ; Plants, Medicinal ; chemistry ; classification ; Selaginellaceae ; chemistry ; classification ; Species Specificity
2.Establishment of an IR-HIRc cell model for screening GFAT inhibitor.
Jiang LI ; Jin-ying TIAN ; Wei-na CONG ; Bing-mu XIN ; Fei YE
Acta Pharmaceutica Sinica 2005;40(5):418-422
AIMTo set up an IR-HIRc cell model for screening the inhibitor of GFAT (glutamine: fructose-6-phosphate amidotransferase) , the key enzyme in the hexosamine biosynthesis pathway (HBP).
METHODSFor GFAT activity assay, the GDH method was improved by adjusting the value of pH in the reaction system and the concentrations of the reactants. The sensitivity to insulin in the cells was estimated by the measurement of insulin-induced glucose-uptake. The IR-HIRc model was set up by the stimulation of long-action insulin for 36 h. The IR-HIRc model and GDH method was used for screening GFAT inhibitor.
RESULTSWith the administration of 25 nmol x L(-1) long-action insulin in HIRe cells for 36 hours, the GFAT activity increased by 47% and the insulin-induced glucose-uptake decreased by 21%. Azaserine, a GFAT inhibitor, inhibited GFAT activity significantly in a dose-dependent manner in IR-HIRc model.
CONCLUSIONWith the stimulation of 25 nmol x L(-1) long-action insulin for 36 h, excess hexosamine flux and insulin resistant in IR-HIRc cell model was set up, which can be used for screening
Animals ; Azaserine ; administration & dosage ; pharmacology ; Cell Line ; Dose-Response Relationship, Drug ; Fibroblasts ; cytology ; metabolism ; Glucose ; metabolism ; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) ; antagonists & inhibitors ; metabolism ; Hexosamines ; biosynthesis ; Insulin ; pharmacology ; Insulin Resistance ; Models, Biological ; Rats ; Recombinant Proteins ; metabolism
3. Management of toxicities associated with pegaspargase in treatment of patients with lymphoid malignancy: experience from 443 cases in a single center
Jia CONG ; Lei YANG ; Jin YE ; Liqiang WEI ; Xin LI ; Jingwen WANG
Chinese Journal of Hematology 2018;39(8):654-660
Objective:
To summarize the adverse effects of pegaspargase in the treatment of lymphoid malignancies and management experience.
Methods:
Clinical data of patients who received chemotherapy including pegaspargase in the Department of Hematology of Beijing Tongren hospital during August 2011 to December 2015 were retrospective analyzed, and the adverse effects of pegaspargase and the management experience was summarized.
Results:
A total of 129 patients with 443 times of pegaspargase used during this period. The common adverse reactions included allergic reactions in 2 cases (1.6%), acute pancreatitis in 19 (14.7%) including 6 acute symptomatic pancreatitis and 13 chemical pancreatitis with elevated pancreatin, hypertriglyceridemia in 15 cases(11.6%), hyperglycemia in 85 (65.9%), hypoglycemia in 7 (5.4%), elevated aminotransferase in 25 (19.4%), hyperbilirubinemia in 21 (15.5%), hypoalbuminemia in 62 (48.1%), prolonged APTT in 61 (47.3%), prolonged PT in 22 (17.1%), prolonged TT in 15 (11.6%), hypofibrinogen in 75 (58.1%), thrombus in 11 (8.5%) and bleeding in 3 (2.3%). The above adverse reactions were improved by symptomatic treatment of anti allergy, inhibition of secretion of pancreatic juice, lipid lowering, hypoglycemic, liver preservation, supplementation of plasma and hemostasis, respectively. Some serious adverse reactions affected the application of pegaspargase, even lead to discontinuation of the aspartate.
Conclusion
Though adverse effects associated with pegaspargase are extensive, most patients can successfully complete the chemotherapy containing the pegaspargase with close monitoring and timely treatment.
4.Biological characters of hepatitis B virus transgenic mice strain C57-TgN(HBV adr2. 0)SMMU
Xiaoyuan ZI ; Yucheng YAO ; Jun XIONG ; Yanhua JIN ; Xuting YE ; Jianxiu LI ; Hong LIU ; Haiying ZHU ; Xinmin WANG ; Wenjun NI ; Hongyu YU ; Wenming CONG ; Yiping HU
Academic Journal of Second Military Medical University 2000;0(11):-
Objective:To evaluate the biological characters of C57-TgN(HBV adr2.0)SMMU transgenic mice. Methods: Integration,expression,replication and histology change of hepatitis B virus gene in F6 transgenic mice were estimated by ge-nomic DNA PCR,Western blotting,ELISA,immunohistochemistry,serum DNA PCR,transmission electron microscopy and H-E staining. Results: Hepatitis B virus gene was integrated into F6 C57-TgN(HBV adr2. 0)SMMU transgenic mice and expressed HBsAg,HBcAg and X protein in liver tissue. HBsAg and HBeAg were expressed in serum of 19. 54% and 3. 39% F6 transgenic mice. Hepatitis B virus were replicated in serum and liver tissue of transgenic mice. Long-term integration,expression and replication of hepatitis B virus gene induced pathological lesion of transgenic mice liver and lung. Conclusion: C57-TgNCHBV adr2. 0)SMMU transgenic mice line has the biological characters including integration of hepatitis B virus gene into genomic DNA,expression and replication of hepatitis B virus gene in serum and liver, and histological change in liver and lung. It is a valuable animal system to study pathogenesis, treatment and prevention of hepatitis B virus.
5.Management of toxicities associated with pegaspargase in treatment of patients with lymphoid malignancy: experience from 443 cases in a single center.
Jia CONG ; Lei YANG ; Jin YE ; Li Qiang WEI ; Xin LI ; Jing Wen WANG
Chinese Journal of Hematology 2018;39(8):654-660
Objective: To summarize the adverse effects of pegaspargase in the treatment of lymphoid malignancies and management experience. Methods: Clinical data of patients who received chemotherapy including pegaspargase in the Department of Hematology of Beijing Tongren hospital during August 2011 to December 2015 were retrospective analyzed, and the adverse effects of pegaspargase and the management experience was summarized. Results: A total of 129 patients with 443 times of pegaspargase used during this period. The common adverse reactions included allergic reactions in 2 cases (1.6%), acute pancreatitis in 19 (14.7%) including 6 acute symptomatic pancreatitis and 13 chemical pancreatitis with elevated pancreatin, hypertriglyceridemia in 15 cases(11.6%), hyperglycemia in 85 (65.9%), hypoglycemia in 7 (5.4%), elevated aminotransferase in 25 (19.4%), hyperbilirubinemia in 21 (15.5%), hypoalbuminemia in 62 (48.1%), prolonged APTT in 61 (47.3%), prolonged PT in 22 (17.1%), prolonged TT in 15 (11.6%), hypofibrinogen in 75 (58.1%), thrombus in 11 (8.5%) and bleeding in 3 (2.3%). The above adverse reactions were improved by symptomatic treatment of anti allergy, inhibition of secretion of pancreatic juice, lipid lowering, hypoglycemic, liver preservation, supplementation of plasma and hemostasis, respectively. Some serious adverse reactions affected the application of pegaspargase, even lead to discontinuation of the aspartate. Conclusion: Though adverse effects associated with pegaspargase are extensive, most patients can successfully complete the chemotherapy containing the pegaspargase with close monitoring and timely treatment.
Asparaginase/metabolism*
;
Humans
;
Polyethylene Glycols/metabolism*
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
Retrospective Studies
6.Cosmetics use-related adverse events
Yang SU-LIAN ; Zheng YUE ; Zhang YUN-QING ; Ye CONG-XIU ; Yi JIN-LING ; Liu YU-FANG ; Lai WEI
Chinese Medical Journal 2019;132(17):2135-2136
7.A Trichophyton Rubrum Infection Model Based on the Reconstructed Human Epidermis - Episkin®.
Pan-Pan LIANG ; Xin-Zhu HUANG ; Jin-Ling YI ; Zhi-Rui CHEN ; Han MA ; Cong-Xiu YE ; Xian-Yan CHEN ; Wei LAI ; Jian CHEN
Chinese Medical Journal 2016;129(1):54-58
BACKGROUNDTrichophyton rubrum represents the most common infectious fungus responsible for dermatophytosis in human, but the mechanism involved is still not completely understood. An appropriate model constructed to simulate host infection is the prerequisite to study the pathogenesis of dermatophytosis caused by T. rubrum. In this study, we intended to develop a new T. rubrum infection model in vitro, using the three-dimensional reconstructed epidermis - EpiSkin ®, and to pave the way for further investigation of the mechanisms involved in T. rubrum infection.
METHODSThe reconstructed human epidermis (RHE) was infected by inoculating low-dose (400 conidia) and high-dose (4000 conidia) T. rubrum conidia to optimize the infection dose. During the various periods after infection, the samples were processed for pathological examination and scanning electron microscopy (SEM) observation.
RESULTSThe histological analysis of RHE revealed a fully differentiated epidermis with a functional stratum corneum, which was analogous to the normal human epidermis. The results of hematoxylin and eosin staining and the periodic acid-Schiff staining showed that the infection dose of 400 conidia was in accord with the pathological characteristics of host dermatophytosis caused by T. rubrum. SEM observations further exhibited the process of T. rubrum infection in an intuitionistic way.
CONCLUSIONSWe established the T. rubrum infection model on RHE in vitro successfully. It is a promising model for further investigation of the mechanisms involved in T. rubrum infection.
Animals ; Disease Models, Animal ; Epidermis ; microbiology ; Humans ; Keratinocytes ; cytology ; Tissue Culture Techniques ; Trichophyton ; pathogenicity
8.Correlation between RARbeta gene promoter methylation and P53 gene mutations in non-small cell lung cancer.
Cong TAN ; Yong-tang JIN ; He-yun XU ; Chen-ye ZHANG ; Hu ZHANG ; Wei-min ZHANG ; Chun-mei CHEN ; Xiao-yu SUN
Chinese Journal of Medical Genetics 2012;29(2):131-136
OBJECTIVETo investigate the correlation between RARbeta gene promoter methylation and P53 gene mutations in non-small cell lung cancer (NSCLC).
METHODSPromoter methylation of RARbeta and P53 mutations of exons 5 through 9 in 198 resected primary NSCLC tissues were determined by methylation-specific PCR and direct sequencing.
RESULTSRARbeta gene promoter methylation and P53 mutation were detected in 58.1% and 36.4% of tumors, respectively. Both were higher in males than in females and in smokers than in nonsmokers. A higher prevalence of RARbeta promoter methylation was found in patients with advanced stage tumors than those with TNM stage I. P53 gene mutations were more frequent in squamous cell carcinoma and adeno-squamous carcinoma than adenocarcinoma. All such differences were statistically significant (P< 0.05). Frequencies of P53 mutations, including G:C>T:A mutations, transversions and missense mutations were significantly higher in tumors with RARbeta methylation than in those without (P< 0.05). A significantly higher prevalence of RARbeta methylation was found in tumors with only G:C>T:A mutation in P53 gene than those without P53 mutations (P< 0.05). This difference (OR=3.737, 95%CI: 1.414-9.873) was still statistically significant (P< 0.05) in smokers (OR=4.020, 95%CI: 1.263-12.800), squamous cell carcinomas (OR=5.480, 95%CI: 1.400-21.446) or patients with advanced tumors (OR=3.446, 95%CI: 1.054-11.267) after adjusting for age and sex.
CONCLUSIONRARbeta methylation is associated with G:C>T:A mutations in P53 gene in NSCLC.
Adult ; Aged ; Base Sequence ; Carcinoma, Non-Small-Cell Lung ; genetics ; pathology ; DNA Methylation ; Female ; Genes, p53 ; Genetic Predisposition to Disease ; Humans ; Lung Neoplasms ; genetics ; pathology ; Male ; Middle Aged ; Molecular Sequence Data ; Mutation ; Promoter Regions, Genetic ; Receptors, Retinoic Acid ; genetics
9.Retrospective review of 190 patients treated for parotid tumors: a single institute experience.
Jing-jia LI ; Ge-hua ZHANG ; Xian LIU ; Jin YE ; Qin-tai YANG ; Jian-cong HUANG ; Si WU ; Gen-di YIN
Chinese Medical Journal 2013;126(5):988-990
Adult
;
Female
;
Humans
;
Male
;
Middle Aged
;
Parotid Neoplasms
;
diagnosis
;
pathology
;
surgery
;
Retrospective Studies
10.Standardized manipulations of sharp hooked needling for treating migraine and investigation on its mechanisms.
Cong-ni JIN ; Tian-sheng ZHANG ; Fang GUAN ; Lai-xi JI ; Lei LI ; Xin-hua LI ; Shi-fei HAO ; Ye YUAN
Chinese Acupuncture & Moxibustion 2009;29(6):508-509
A comparison of recognition to migraine and treatment methods for it was made between traditional Chinese medicine and western medicine in this paper. Emphasis was made on standardized manipulation processes and techniques of sharp hooked needling for treating the disease, based on both the organic conception of the human body, the theory held by TCM, and on the principle of treatment according to pathogenesis obtained through differentiation of symptoms and signs. The necessary preparation before operations, methods for its application and announcements in the standardized manipulations of sharp hooked needling were all explained in detail. Based on its needling, pricking, dissecting and relaxing effects, the mechanisms of sharp hooked needling in treating the disease were investigated. It is concluded that sharp hooked needling is very effective in treating migraine.
Acupuncture Points
;
Acupuncture Therapy
;
instrumentation
;
methods
;
standards
;
Humans
;
Medicine, Chinese Traditional
;
instrumentation
;
methods
;
standards
;
Migraine Disorders
;
therapy
;
Needles
;
Reference Standards